The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2003
Citation, commencement and interpretation1.
(1)
These Regulations may be cited as the Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2003 and shall come into force on 4th April 2003.
(2)
Amendment of regulation 1 of the principal Regulations2.
In regulation 1 of the principal Regulations (citation, commencement and interpretation), in paragraph (1), in sub-paragraph (a)—
(a)
““district nurse/health visitor prescriber” means—
(a)
a person who—
- (i)
is registered in Part 1 or 12 of the professional register, and
- (ii)
has a district nursing qualification additionally recorded in the professional register under rule 11 of the Nurses, Midwives and Health Visitors Rules 19834; or(b)
a person who is registered in Part 11 of the professional register as a health visitor,
against whose name (in each case) is recorded in the professional register an annotation signifying that he is qualified to order drugs, medicines and appliances for patients;”;
(b)
““Extended Formulary” means the Nurse Prescribers' Extended Formulary Appendix in the current edition of the British National Formulary;
“extended formulary nurse prescriber” means a person—
(a)
who is a first level nurse, and
(b)
against whose name is recorded in the professional register an annotation signifying that he is qualified to order drugs, medicines and appliances from the Extended Formulary;
“first level nurse” means a person registered in Parts 1, 3, 5, 8, 10, 11, 12, 13, 14 or 15 of the professional register;”;
(c)
““health care” means services for or in connection with the prevention, diagnosis or treatment of disease;”;
(d)
in the definition of “health prescription”, for “or dentist” substitute “, a dentist, a supplementary prescriber, a district nurse/health visitor prescriber or an extended formulary nurse prescriber”;
(e)
““independent clinic”—
“independent hospital”—
- (a)
in relation to England and Wales, shall be construed in accordance with section 2(2), (3) and (6) of the Care Standards Act 2000, and
- (b)
in relation to Scotland, means—
- (i)
an independent hospital, or
- (ii)
a private psychiatric hospital,
as defined by section 77(1) of the Regulation of Care (Scotland) Act 2001;
“independent medical agency”—
- (a)
in relation to England and Wales, has the meaning given by section 2(5) of the Care Standards Act 2000, and
- (b)
in relation to Scotland, has the meaning given by section 77(1) of the Regulation of Care (Scotland) Act 2001;”;
(f)
in the definition of “prescription only medicine”, for “Prescription Only Order” substitute “Prescription Only Medicines Order”;
(g)
““the Prescription Only Medicines Order” means the Prescription Only Medicines (Human Use) Order 19979;”;
(h)
““prison service” means—
(a)
in relation to England and Wales, a Minister of the Crown exercising functions in relation to prisons (within the meaning of the Prison Act 195211),(b)
in relation to Scotland, the Scottish Ministers exercising functions in relation to prisons (within the meaning of the Prisons (Scotland) Act 198912), and(c)
in relation to Northern Ireland, the Northern Ireland Department exercising functions in relation to prisons (within the meaning of the Prison Act (Northern Ireland) 195313);
(i)
““relevant register” means—
(a)
in relation to a first level nurse, the professional register, and
(j)
““supplementary prescriber” means—
(a)
a first level nurse, or
(b)
a pharmacist,
against whose name is recorded in the relevant register an annotation signifying that he is qualified to order drugs, medicines and appliances as a supplementary prescriber;”.
Amendment of regulation 5 of the principal Regulations3.
Regulation 5 of the principal Regulations (restrictions on persons to be supplied with certain medicinal products), in paragraph (2)—
(a)
in sub-paragraph (a), for “column 1 of Schedule 4 to the Prescription Only Order” substitute “column 1 of Schedule 5 to the Prescription Only Medicines Order”;
(b)
in sub-paragraph (b), for “Article 8 of the Prescription Only Order” substitute “Article 10 of the Prescription Only Medicines Order”; and
(c)
sub-paragraph (d) is omitted.
Amendment of regulation 6 of the principal Regulations4.
(a)
in paragraph (1), in sub-paragraph (b), for “Article 6(1) of the Prescription Only Order” substitute “Article 8(1) of the Prescription Only Medicines Order”; and
(b)
in paragraph (3), in sub-paragraph (d), for “column 3 of Schedule 4 to the Prescription Only Order” substitute “column 3 of Schedule 5 to the Prescription Only Medicines Order”.
Amendment of Schedule 1 to the principal Regulations5.
In Schedule 1 to the principal Regulations (classes of persons for the purposes of regulation 5)—
(a)
“Authorities or persons carrying on the business of—
- (a)
an independent hospital, independent clinic or independent medical agency, or
- (b)
a hospital or health centre which is not an independent hospital or independent clinic.”; and
(b)
“A person other than an excepted person who carries on a business consisting (wholly or partly) of the supply or administration of medicinal products for the purpose of assisting the provision of health care by or on behalf of, or under arrangements made by—
- (a)
a police force in England, Wales or Scotland,
- (b)
the Police Service of Northern Ireland,
- (c)
a prison service, or
- (d)
Her Majesty’s Forces.”.
Amendment of Schedule 2 to the principal Regulations6.
(a)
in paragraph 1—
(i)
for “a practitioner or under Article 6(1) of the Prescription Only Order” substitute “a practitioner, a supplementary prescriber, a district nurse/health visitor prescriber or an extended formulary nurse prescriber, or under Article 8(1) of the Prescription Only Medicines Order”,
(ii)
in sub-paragraph (c), after “the practitioner” insert “, supplementary prescriber, district nurse/health visitor prescriber or extended formulary nurse prescriber”, and
(iii)
in sub-paragraph (f), for “Article 6(1) of the Prescription Only Order” substitute “Article 8(1) of the Prescription Only Medicines Order”;
(b)
in paragraph 3, for “Article 6(3) of the Prescription Only Order” substitute “Article 8(3) of the Prescription Only Medicines Order”; and
(c)
in paragraph 4, for “Article 6 of the Prescription Only Order” substitute “Article 8 of the Prescription Only Medicines Order”.
Signed by authority of the Secretary of State for Health
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
Sealed with the Official Seal of the Department of Agriculture and Rural Development
These Regulations further amend the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 (“the principal Regulations”) which impose restrictions on the sale and supply of medicinal products.
Regulation 6 of, and Schedule 2 to, the principal Regulations imposes a requirement on persons conducting a retail pharmacy business to record the sale or supply of a prescription only medicine except in specified circumstances such as the sale or supply having been made pursuant to a prescription issued under or by virtue of legislation relating to the National Health Service. Regulations 2(a), (b), (d) and (h) to (j), 4 and 6 of these Regulations amends these provisions so as to include references to prescriptions written by supplementary prescribers, district nurse/health visitor prescribers and extended formulary nurse prescribers.
Schedule 1 to the principal Regulations specifies persons who may, subject to exemptions specified in the principal Regulations, be supplied with certain medicinal products. Regulation 5 of these Regulations adds—
authorities or persons carrying on the business of independent hospitals, clinics and medical agencies, and
persons who carry on a business consisting (wholly or partly) of the supply or administration of medicinal products for the purpose of assisting the provision of health care by the police, the prison services or the armed forces,
to the list of bodies specified in Schedule 1.
A Regulatory Impact Assessment in relation to these Regulations has been placed in the libraries of both Houses of Parliament and copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.